STAT+: Pharmalittle: Europe isn’t ruling out waiving IP rights for Covid-19 shots; AstraZeneca defends vaccine production process

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say “Every brand new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Remember, a prescription is not required. Meanwhile, here are a few items of interest. Hope you have a smashing day and, of course, do stay in touch. …

The World Health Organization vaccine safety panel is now due to issue its findings on the AstraZeneca (AZN) Covid-19 shot on Friday, Reuters says. The WHO global advisory committee on vaccine safety examined the data on Tuesday and reviewed reports of rare blood coagulation disorders in people who had received the shot. Meanwhile, the European Medicines Agency is due to report later today on its review of a small number of reports of bleeding, blood clots, and low platelet counts in people who have received the AstraZeneca vaccine.

Continue to STAT+ to read the full story…

STAT+: Pharmalittle: Europe isn’t ruling out waiving IP rights for Covid-19 shots; AstraZeneca defends vaccine production process

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top